I heard gustafson passed and the holder now is a special purpose company directed towards early investment in disruptive bio tech and other similar value/ growth prospective investments quite an impressive record there i saw was a very early investor on par, zoono, anp , openpay splitit etc although has sold down in many after multi factor value increases
still in rce and i see increasing the holding i think bodes well
RCE Price at posting:
$1.15 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)